• Trial Status
  • Patients randomised:
  • 4662

Brief Summary

This 5 year multicentre large randomised trial is designed to answer two clinically important questions:

  1. Should low-dose aspirin be continued up until the day of CABG surgery?
  2. Should tranexamic acid be used for all at-risk CABG surgery?

The trial commenced enrolment in April 2006.

Main Study Hypothesis

In patients undergoing elective coronary artery surgery and at increased risk of complications, aspirin and/or tranexamic acid will reduce the incidence of mortality or major morbidity when compared with those not receiving such therapy.


Australian NHMRC Project Grant (ID 334015)


ACTRN No. ACTRN012605000557639

For further information contact

Sophie Wallace

or click Register your interest